LOMEVO is a prospective, multicenter, real-world registry lasting for 10 years. A total of 50000 patients with large- or medium-vessel occlusion will be enrolled at approximately 30 centers around China.
This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.